Home > Boards > US Listed > Biotechs > PDL BioPharma Inc. (PDLI)

Goldman-Sachs Conference Updates

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ECole Member Profile
 
Followed By 20
Posts 1,363
Boards Moderated 1
Alias Born 07/02/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2019 8:34:15 AM
PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024 PR Newswire (US) - 12/13/2019 8:30:00 AM
SevenSaoi Capital Supportive of PDL BioPharma Announcement PR Newswire (US) - 12/10/2019 3:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2019 8:04:56 AM
PDL BioPharma Announces Completion of Strategic Review Process PR Newswire (US) - 12/9/2019 8:00:00 AM
PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Ca... PR Newswire (US) - 12/3/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 6:03:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/14/2019 1:21:55 PM
PDL BioPharma Reaffirms Commitment To Shareholder Value Creation PR Newswire (US) - 11/14/2019 8:56:00 AM
Engine Capital Releases Presentation To Board Of PDL BioPharma PR Newswire (US) - 11/14/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 4:16:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 4:11:56 PM
PDL BioPharma Reports 2019 Third Quarter Financial Results PR Newswire (US) - 11/6/2019 4:05:00 PM
PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019 PR Newswire (US) - 10/30/2019 9:00:00 AM
PDL BioPharma Responds to Letter from Engine Capital PR Newswire (US) - 10/24/2019 10:06:00 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/23/2019 8:57:33 AM
Engine Capital Issues Open Letter to Board of PDL BioPharma PR Newswire (US) - 10/23/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2019 7:06:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:01:36 AM
PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference PR Newswire (US) - 9/26/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 5:09:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 6:01:39 AM
PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024 PR Newswire (US) - 9/12/2019 10:20:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2019 6:02:29 AM
PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation PR Newswire (US) - 9/11/2019 10:44:00 PM
ECole   Friday, 07/12/13 09:39:23 AM
Re: None
Post # of 207 
Goldman-Sachs Conference Updates

Valuable remarks.. Annual-Global-Healthcare-Conference
Read here

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2019 InvestorsHub.com, Inc.